abstract |
The present invention relates to in vitro methods for determining the prognosis of an individual diagnosed with mammary cancer developing metastasis or to select appropriate treatment for said individual. In particular, the invention relates to a gene signature expression whereof is correlated with the prognosis of an individual diagnosed with mammary cancer. |